Skip to main content
Equibles

Roopal Thakkar

AbbVie Inc. (ABBV)

Equibles does not estimate personal net worth.

Get an email with a short summary when AbbVie Inc. publishes a filing, an earnings call transcript or a press release.

Get ABBV alerts

About Roopal Thakkar

Roopal Thakkar has spoken on 2 earnings calls and 4 other investor events across 1 company, most recently for AbbVie Inc. on September 15, 2026. AbbVie Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at AbbVie Inc. includes Robert A. Michael (CEO, Chairman, CFO, COO and Board Member), Richard A. Gonzalez (Chairman), Scott T. Reents (CFO) and 5 others.

Roopal Thakkar on recent calls

“Yeah, so very consistent with the data that we just saw, which was the Phase 2B data set that Rob's referencing.”
Other, Morgan Stanley 24th Annual Global Healthcare Conference ·
“This transaction adds a portfolio of novel, long-acting antibodies that further strengthen our immunology pipeline. AbbVie has more than two decades of experience developing differentiated therapies in immunology.”
Other, AbbVie Apogee Acquisition Conference Call ·
“Yeah, just coming out of ASCO is an exciting time. a lot of interesting developments, PD-1, VEGF space, KRAS space, and these are both areas that we're participating in, in particular combination approaches with our ADC portfolio.”
Other, Goldman Sachs 47th Annual Global Healthcare Conference ·
“And we don't specifically constrain early in one therapeutic area or middle or late. If we see something that's attractive, that's early or middle, mid-stage, the team is free to go look at that.”
Other, Bank of America Securities Healthcare Conference ·
“We continue to make good progress across our pipeline. I'll start with dermatology programs in immunology.”
Other, AbbVie Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at AbbVie Inc.

Recent activity